News

Gladstone in the News June 15, 2026

What COVID Is Teaching Doctors About the Relationship Between Viruses and Cancer

Los Angeles Times—Melanie Ott, director of the Gladstone Infectious Disease Institute, comments on emerging evidence that viral infections like COVID-19 may help reactivate dormant cancer cells, highlighting the need for more research into the links between viruses, inflammation, and cancer recurrence. (Subscription required.)

Ott Lab Infectious Disease COVID-19 Cancer

Gladstone in the News June 10, 2026

Is the Peptide Craze Backed by Science? The Promise Behind the Hype

Peptides have become the latest cure-all trend on social media, but is the hype warranted? Deepak Srivastava warns that public enthusiasm may have surpassed the science.

Gladstone Experts

Article June 9, 2026

How an AI Microscope Is Learning to Do Science

Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.

Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease

Video June 9, 2026

This Is AI Designing Its Own Experiments

Gladstone scientists have developed a thinking microscope powered by artificial intelligence.

AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS

Article June 8, 2026

New CRISPR Technique Selectively Shreds Cancer Cells, Including Those of ‘Undruggable’ Cancers

An innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact.

News Release Research (Publication) Doudna Lab CRISPR/Gene Editing Cancer

Gladstone in the News June 8, 2026

CRISPR Shreds Undruggable Cancer Cells with Precision

Genetic Engineering & Biotechnology News—Gladstone Investigator Jennifer Doudna and collaborators developed a CRISPR-based strategy that selectively destroys cancer cells with p53 mutations, opening a potential new path for treating some of the deadliest cancers.

Doudna Lab CRISPR/Gene Editing

Article June 2, 2026

Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections

The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.

News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AI

Article June 1, 2026

Gladstone Investigator Andrew Yang Receives 2026 Sobrato Prize in Neuroscience

The prize honors scientists whose breakthroughs in brain research have high potential for patient impact.

Philanthropy Awards News Release Alzheimer’s Disease Neurological Disease Yang Lab

Article May 29, 2026

Mapping How the Brain Takes Out Its Trash

Gladstone scientists developed a new tool to trace how the brain clears “waste,” uncovering surprising new biology about how it keeps itself healthy.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Yang Lab

Gladstone in the News May 28, 2026

Gene Therapies to Fix Failing Hearts Gain Steam After Years in the Doldroms

Nature—Gladstone President Deepak Srivastava comments on the strong preclinical data supporting a first-in-human gene therapy designed to stimulate heart-muscle regeneration. (Subscription required.)

Heart Failure Congenital Heart Disease

Gladstone in the News May 27, 2026

Heart Patch Engineered From Stem Cells Revved Up Weakened Hearts

STAT—Gladstone President Deepak Srivastava offers commentary on a novel approach to heart failure that involves a stem cell-based patch to regenerate cardiac muscle.

Congenital Heart Disease Heart Failure

Gladstone in the News May 15, 2026

The Resilient Brain

Health Channel—In this video, Gladstone Investigator Yadong Huang explains how repurposed drugs that are already approved by the FDA can expedite potential new treatments for Alzheimer’s disease.

Gladstone in the News May 15, 2026

Gladstone Women’s Health Researchers Confront Dei Backlash, Privacy Fears

San Francisco Business Times—Gladstone Investigator Barbara Engelhardt is leading menstrual-cycle research aimed at collecting biometric data from more diverse populations while carefully considering participant privacy and data security.

Engelhardt Lab Gladstone Experts

Article May 8, 2026

A New Pandemic Threat? Unpacking the Hantavirus Cruise Ship Outbreak

Gladstone virologist Melanie Ott explains why this rare, person-to-person hantavirus strain illustrates the need for diligent pandemic preparedness.

Infectious Disease Krogan Lab Ott Lab

Article April 30, 2026

A Gene That Keeps Stem Cells From Losing Their Way

Scientists find a gene essential for keeping intestinal stem cells stable, offering insight into how tissues repair themselves.

News Release Research (Publication) Yamanaka Lab Stem Cells/iPSCs